Details for New Drug Application (NDA): 214543
✉ Email this page to a colleague
The generic ingredient in DROXIDOPA is droxidopa. There are six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the droxidopa profile page.
Summary for 214543
Tradename: | DROXIDOPA |
Applicant: | Somerset Theraps Llc |
Ingredient: | droxidopa |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 214543
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | May 5, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | May 5, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
Approval Date: | May 5, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription